† Polymer Research Centre, Department of Chemical Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, West Bengal 741246, India ‡ Department of Biological Sciences, Indian ...

dadlnet.dk Objective There is a lack of disease-modifying treatments in hypertrophic cardiomyopathy (HCM). The aim of this randomised, placebo-controlled study was to assess if losartan could improve ...

Hypertrophic cardiomyopathy is a common yet under-recognized genetic structural heart condition characterized by left ventricular hypertrophy. Patients may present with obstructive disease ...

This new effort builds on the American Heart Association’s ongoing commitment to improving diagnosis, care and outcomes for people with cardiomyopathy. The objectives are to close knowledge gaps ...

The FDA has approved the drug Camzyos to treat obstructive hypertrophic cardiomyopathy (HCM). A second drug is currently under review. Other medications and lifestyle strategies can also help ...

Topline results were announced from a phase 3 study comparing aficamten with metoprolol in adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM). The randomized, double-blind, ...

The syndrome, which doctors formally call takotsubo cardiomyopathy, is thought to be triggered by physical or emotional stress, which releases bursts of stress hormones like adrenaline that ...

Takotsubo cardiomyopathy continues to be a major cause of mortality and morbidity. The goal of this study was to evaluate the outcome data of patients with Takotsubo cardiomyopathy using a large ...

dilated cardiomyopathy (DCM). Furthermore, the CMR-derived biomarkers of fibrosis (based on ECV) and strain are prognostic for major adverse cardiovascular events (MACE) during the disease's ...